Month: May 2025

Boosting Muscle and Fat Loss with GLP-1s

by

This talk at the discuss the development of new medications designed to address muscle loss that can occur alongside weight loss achieved with GLP-1 receptor agonists like semaglutide and tirzepatide. While these powerful weight loss drugs are effective, a significant portion of the lost weight is lean body mass, raising concerns about potential long-term effects on physical function and health. Several investigational drugs, including SARMs and antimostatin agents, … Read more

I bought fat jab on Facebook for £150 then blacked out & almost died – when docs told me what was in it I was horrified

by

TEARS prick Michelle Sword’s eyes as she scrolls through photos of herself in hospital, tubes snaking in and out of her body. The 45-year-old wasn’t there for a routine operation – she was fighting for her life after unknowingly injecting herself with fake Ozempic bought from a Facebook seller. Michelle Sword was left fighting for … Read more

GLP-1s: 8 things hospital leaders should know

by

Here are eight things health system and hospital leaders should know about these medications: 1. What does “GLP-1” mean? The acronym stands for glucagon-like peptide-1 receptor agonist. The gut hormone prompts insulin secretion, suppresses appetite and promotes a feeling of fullness. GLP-1 drugs mimic these physiological effects. 2. Which medications are approved? As of May … Read more

Barron’s: Novo Nordisk Says CEO to Step Down

by

From Barron’s Novo Nordisk _ CEO Lars Fruergaard Jørgensen will step down as CEO of the Danish maker of GLP-1 drugs Ozempic and Wegovy. It was a “mutual agreement,” Novo said in a statement Friday. The search for Fruergaard Jørgensen’s successor is ongoing, the company added. Novo Nordisk stock was up about 1.8% in Denmark. … Read more

“Ozempic Tongue” Is The Latest “Nasty” Side Effect Of Weight-Loss Meds, As More Celebs Speak Out

by

A growing number of users say Ozempic is rewiring their taste buds in ways they never saw coming. The blockbuster weight loss drug isn’t just shrinking waistlines. It’s changing how people experience food altogether, leading to the phenomenon that’s now being called the Ozempic tongue. It takes away “all the joy of eating away,” one said … Read more

The Beachbody Company, Inc. (NYSE:BODI) Q1 2025 Earnings Call Transcript

by

The Beachbody Company, Inc. (NYSE:BODI) Q1 2025 Earnings Call Transcript May 14, 2025 Operator: Good afternoon. Thank you for attending today’s Beachbody Company, Inc. First Quarter 2025 Earnings Conference Call. My name is Victoria and I will be your moderator for today’s call. All lines will be muted during the presentation portion of the call … Read more

Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries

by

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective treatments for type 2 diabetes (T2DM), obesity, and cardiovascular disease.1–3 Beyond these indications, they have shown promising clinical efficacy in conditions such as chronic kidney disease, metabolic dysfunction–associated steatohepatitis, obstructive sleep apnea, and Parkinson’s disease.4–6 With proven efficacy and increasing global use, there is a growing need … Read more

Facebook Twitter
© Copyright 2025 GenWeb of Texas